Ann Hynes analyst MIZUHO

Currently out of the existing stock ratings of Ann Hynes, 196 are a HOLD (36.7%), 338 are a BUY (63.3%).

Ann Hynes

Work Performance Price Targets & Ratings Chart

Analyst Ann Hynes, currently employed at MIZUHO, carries an average stock price target met ratio of 73.32% that have a potential upside of 13.59% achieved within 183 days.

Ann Hynes’s has documented 1,019 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Communication Services sectors.

Most recent stock forecast was given on ACHC, Acadia Healthcare Company at 18-Dec-2025.

Wall Street Analyst Ann Hynes

Analyst best performing recommendations are on BTSG (BRIGHTSPRING HEALTH SERVICES, COMMON STOCK).
The best stock recommendation documented was for DPLO (DIPLOMAT PHARMACY) at 11/7/2017. The price target of $20 was fulfilled within 1 day with a profit of $1.25 (6.67%) receiving and performance score of 66.67.

Average potential price target upside

ACHC Acadia Healthcare Company ANTM Anthem CAH Cardinal Health CI Cigna Corp CNC Centene Corp CVS CVS Health Corp DGX Quest Diagnostics EHC Encompass Health Corp HCA HCA Holdings HUM Humana ICLR ICON PLC IQV IQVIA Holdings LH Laboratory of America Holdings MCK McKesson MD Mednax MOH Molina Healthcare PRAH PRA Health Sciences THC Tenet Healthcare UHS Universal Health Services WBA Walgreens Boots Alliance ABC AmerisourceBergen DPLO Diplomat Pharmacy EVHC Envision Healthcare Holdings PPD PPD RAD Rite Aid SYNH Syneos Health UNH UnitedHealth Group ELV Elevance Health SGRY Surgery Partners IQ iQIYI CRL Charles River Laboratories BTSG BrightSpring Health Services, Common Stock FTRE Fortrea Holdings MEDP Medpace Holdings Q Quintiles Transnational

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Feb-2021

$15

$-0.23 (-1.51%)

$95

4 days ago
(22-Jan-2026)

19/20 (95%)

$0.67 (4.68%)

1043

Buy Since 12-Dec-2022

$17

$1.77 (11.62%)

$19

12 days ago
(14-Jan-2026)

0/13 (0%)

$5.27 (44.93%)

Hold Since 30-Oct-2017

$17

$1.77 (11.62%)

$22

1 months 8 days ago
(18-Dec-2025)

19/25 (76%)

$2.57 (17.81%)

76

Hold Since 04-Dec-2025

$14

$-1.23 (-8.08%)

$28

1 months 22 days ago
(04-Dec-2025)

5/17 (29.41%)

$-0.64 (-4.37%)

124

Buy Since 17-Nov-2020

$14

$-1.23 (-8.08%)

$40

1 months 23 days ago
(03-Dec-2025)

9/12 (75%)

$-2.49 (-15.10%)

381

Show more analysts

Please expand the browser size to see the chart

Which stock is Ann Hynes is most bullish on?

Potential upside of $78.5 has been obtained for HUM (HUMANA)

Which stock is Ann Hynes is most reserved on?

Potential downside of -$19.61 has been obtained for CRL (CHARLES RIVER LABORATORIES)

What Year was the first public recommendation made by Ann Hynes?

On 2011

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?